Glenmark Pharmaceuticals informs about press release

30 Sep 2021 Evaluate

Glenmark Pharmaceuticals has informed that it enclosed a media release dated September 30, 2021 titled ‘Glenmark receives marketing approval for Ryaltris, an innovative combination nasal spray, in 13 countries across the EU and UK’.

The above information is a part of company’s filings submitted to BSE.

Glenmark Pharma Share Price

1995.90 52.55 (2.70%)
22-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1634.40
Dr. Reddys Lab 1217.15
Cipla 1371.55
Zydus Lifesciences 884.85
Lupin 2165.05
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×